Sintx Technologies (SINT) EBITDA Margin Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -343.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -178.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 487.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -283.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 72.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,505.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -184.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -3,846.00 |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 | -18,402.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18,402.00 |
| Dec 31, 2025 | 252,384.00 |
| Sep 30, 2025 | -95,735.00 |
| Jun 30, 2025 | -60,532.00 |
| Mar 31, 2025 | 158,676.00 |
| Dec 31, 2024 | 125,075.00 |
| Sep 30, 2024 | 38,001.00 |
| Jun 30, 2024 | 202,412.00 |
| Mar 31, 2024 | 234,751.00 |
| Dec 31, 2023 | 162,743.00 |
| Sep 30, 2023 | 314,575.00 |
| Jun 30, 2023 | 29,066.00 |
| Mar 31, 2023 | 23,573.00 |
| Dec 31, 2022 | 27,459.00 |
| Sep 30, 2022 | 32,703.00 |
| Jun 30, 2022 | -24,821.00 |
| Mar 31, 2022 | -44,905.00 |
| Jun 30, 2021 | -224,632.00 |
| Mar 31, 2021 | -271,549.00 |
| Dec 31, 2020 | -202,401.00 |
| Sep 30, 2020 | -367,872.00 |
| Jun 30, 2020 | -97,250.00 |
| Mar 31, 2020 | -89,563.00 |
| Dec 31, 2019 | -59,717.00 |
| Sep 30, 2019 | -85,424.00 |
| Jun 30, 2019 | -78,550.00 |
| Mar 31, 2019 | -170,232.00 |
| Jun 30, 2018 | 3,084.00 |
| Mar 31, 2018 | -1,292.00 |
| Dec 31, 2017 | 28,297.00 |
| Sep 30, 2017 | 8,216.00 |
| Jun 30, 2017 | 22,680.00 |
| Mar 31, 2017 | 8,152.00 |
| Dec 31, 2016 | -6,562.00 |
| Sep 30, 2016 | -8,410.00 |
| Jun 30, 2016 | -7,522.00 |
| Mar 31, 2016 | -1,387.00 |